IKARIA HOLDINGS INC

Profile

Company Names

IKARIA HOLDINGS INC

Addresses

6 ROUTE 173, CLINTON, NJ 08809

Phone Numbers

908-238-6600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$54,947,203.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2008-07-07 
$54,947,203.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALDO 
E. 
BELLONI 
DIRECTOR
IKARIA HOLDINGS INC
MATTHEW 
M. 
BENNETT 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC   |  AYSCO SECURITY CONSULTANTS, LLC   |  BOND VETERINARY, INC.
JAMES 
A. 
BRIGGS 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC   |  ORIX REAL ESTATE CAPITAL HOLDINGS, LLC
MICHAEL 
T. 
FLAHERMAN 
DIRECTOR
IKARIA HOLDINGS INC
MICHAEL 
R. 
KENNEDY 
EXECUTIVE OFFICER
FIRST SOUTHERN BANCORP   |  IKARIA HOLDINGS INC   |  ZYNBIT.COM, INC.
ELIZABETH 
A. 
LARKIN 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC
ROBERT 
T. 
NELSEN 
DIRECTOR
IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  NEUROGESX INC   |  SAGE THERAPEUTICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  GRAIL, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
BRYAN 
E. 
ROBERTS 
DIRECTOR
CERULEAN PHARMA INC.   |  IRONWOOD PHARMACEUTICALS INC   |  IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  ACHAOGEN INC   |  VENROCK ASSOCIATES VI, L.P.   |  VENROCK PARTNERS VI, L.P.   |  VENROCK ASSOCIATES VII, L.P.   |  VENROCK ASSOCIATES VIII, L.P.   |  VENROCK ASSOCIATES IX, L.P.   |  VENROCK ASSOCIATES X, L.P.   |  VENROCK PARTNERS X, L.P.
STEPHEN 
A. 
ROSS 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC
RALF 
H. 
ROSSKAMP 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC
DAVID 
E. 
SHAW 
EXECUTIVE OFFICER, DIRECTOR
IKARIA HOLDINGS INC   |  ITACONIX CORP   |  IRONWOOD PHARMACEUTICALS INC   |  DIRECT VET MARKETING, INC.
ALOK 
 
SINGH 
DIRECTOR
DELTEK, INC   |  IKARIA HOLDINGS INC   |  REDPRAIRIE HOLDING, INC.   |  AMERICAN WHOLESALE INSURANCE HOLDING COMPANY, LLC   |  NM ALPHA ACQUISITION LLC   |  BRIDGE GROWTH PARTNERS, LP   |  BRIDGE GROWTH PARTNERS (PARALLEL), LP   |  TUSCANY PARENT INC.   |  ALPHACAT OPPORTUNITIES LTD.   |  BGP FS PARENT, INC.   |  BETACAT FEEDER FUND I LTD.   |  BGP BRAVO HOLDINGS, LLC   |  BRIDGE GROWTH PARTNERS II, LP   |  BRIDGE GROWTH PARTNERS III, LP   |  BRIDGE GROWTH PARTNERS III (PARALLEL), LP
CSABA 
 
SZABO 
EXECUTIVE OFFICER
IKARIA HOLDINGS INC   |  AQUINOX PHARMACEUTICALS INC
DANIEL 
 
TASSE 
EXECUTIVE OFFICER, DIRECTOR
IKARIA HOLDINGS INC   |  BELLEROPHON THERAPEUTICS LLC   |  COMPOUND HOLDINGS I, LLC   |  BIOQ PHARMA INC   |  ALCRESTA, INC.   |  ALCRESTA THERAPEUTICS, INC.   |  BELLEROPHON THERAPEUTICS, INC.   |  DBV TECHNOLOGIES S.A.
RANDY 
H. 
THURMAN 
DIRECTOR
IKARIA HOLDINGS INC   |  ARNO THERAPEUTICS, INC   |  OUTLOOK THERAPEUTICS, INC.
LOTA 
S. 
ZOTH 
DIRECTOR
IKARIA HOLDINGS INC   |  HYPERION THERAPEUTICS INC   |  INOVIO PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-10-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#